It’s been ten-years since the groundbreaking, life-saving, cancer-fighting drug Gleevec was approved by the Food and Drug Administration. OHSU Doctor Brian Druker, the lead researcher on the drug, says the drug attacks the cancer cells, without attacking the good cells. A celebration hosted by the OHSU knight cancer Institute at south waterfront celebration drew several cancer survivors who probably would have died long ago if not for the drug.